CT引导下125I粒子植入治疗晚期胃癌淋巴结转移

doi:10.6040/j.issn.1671-7554.0.2016.1668

摘要/Abstract

摘要： 目的探讨CT引导下¹²⁵I粒子植入治疗Ⅲ~Ⅳ期胃癌淋巴结转移的安全性及疗效。方法回顾性分析2005年1月至2016年5月晚期胃癌淋巴结转移15例患者的治疗情况,其中淋巴结直径≤5 cm 6例、>5 cm 9例, CT引导下植入¹²⁵I粒子,活度0.3~0.7 mCi,术后验证D90、V100、V150,且与术前进行对比,观察病灶大小及并发症。结果 15例患者均手术顺利,随访时间6~18个月,6个月局部控制率为93.3%、有效率为73.3%,6、12个月生存率分别为100%、31%。D90、V100、V150术前与术后各指标比较差异均无统计学意义(P值分别为0.100、0.628、0.971)。未见大出血、胃穿孔、肠道感染、骨髓抑制、皮肤黏膜反应等并发症。结论 CT引导下¹²⁵I粒子植入治疗Ⅲ~Ⅳ期胃癌淋巴结转移近期疗效较好,是一种安全可行的方法。

关键词: 疗效, 胃肿瘤, 近距离放射治疗, 淋巴结转移

Abstract: Objective To evaluate the safety and effect of ¹²⁵I seed implantation for lymph node metastases in patients with gastric cancer of Ⅲ-Ⅳ stage. Methods The data of 15 gastric cancer patients with lymph node metastases treated by CT-guided ¹²⁵I seed implantation were retrospectively studied from January 2005 to May 2016. Lymph nodes with diameter ≤5 cm in six(33.3%)lesions, >5 cm were observed in nine(66.6%)lesions. Under CT guided implanted ¹²⁵I seed with the activity of 0.3-0.7 mci,postplan was performed after the operation, the D90, V100, V150 pre and post operation were collected and compared. Six months after the treatment reexamination was employed, including lesion size changes and complications. Results The follow-up ranged from 6 to 18 months.The 6 -month local control was 93.3%, the effective rate was 73.3%, The 6-, 12- month of survival rates was 100% and 31%, respectively. The difference of all data between pre and post operation was not statistically significant(P=0.10, P=0.628, P=0.971)in the D90, V100, V150. No major complications such as massive hemorrhage, Gastric perforation,intestinal infection, bone marrow suppression, Reaction of skin and other related to the procedure occurred during the therapy. Conclusion CT guided radioactive ¹²⁵I seed implantation for lymph node metastases in patients with gastric cancer of Ⅲ-Ⅳ stage was a safe and feasible method.

Key words: Brachytherapy, Lymph node metastases, Gastric cancer, Effect

中图分类号:

R816.5

底学敏,牛书雷,赵静,杜随,于慧敏,张宏涛,王娟. CT引导下¹²⁵I粒子植入治疗晚期胃癌淋巴结转移[J]. 山东大学学报（医学版）, 2017, 55(9): 79-84.

DI Xuemin, NIU Shulei, ZHAO Jing, DU Sui, YU Huimin, ZHANG Hongtao, WANG Juan. CT-guided ¹²⁵I seed implantation for lymph node metastases in patients with gastric cancer of later stage[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 79-84.

参考文献

[1] Karpeh MS, Leon L, Klimstra D, et al. Brennan MFLymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients[J]. Ann Surg, 2000, 232(3): 362-371.
[2] Marrelli D, Roviello F, de Manzoni G, et al. Different patterns of recurrence in gastric cancer depending on Laurens histological type: longitudinal study[J]. World J Surg, 2002, 26(9): 1160-1165.
[3] Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy(CLASSIC): a phase 3 open-1abel,randomised controlled trial[J]. Lancet, 2012, 379(9813): 315-321.
[4] Van Cutsem E, de Haas S, Kang YK, et al. Bevacizumab in conbination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial[J]. J Clin Oncol, 2012, 30(17): 2119-2127.
[5] Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma[J]. Br J Surg, 2000, 87(2): 236-242.
[6] 高汝贵,李光,刘泰福,等.现代放射肿瘤学[M].上海:复旦大学出版社,2011: 381.
[7] Wang Z, Lu J, Gong J, et al. CT-guided radioactive ¹²⁵I seed implantation therapy of symptomatic retroperitoneal lymph node metastases[J]. Cardiovasc Intervent Radiol, 2014, 37(1): 125-131.
[8] Gao F, Gu YK, Huang JH, et al. Clinical value of CT-guided ¹²⁵I brachytherapy for retroperitoneal metastatic lymph node from PHC[J]. Zhonghua Yi Xue Za Zhi, 2013, 93(27): 2155-2157.
[9] Liu B, Zhou T, Li Y, et al. Percutaneous computed tomography-guided iodine-125 seeds implantation for unresectable pancreas[J]. Indian J Cancer, 2015, 52(2): 69-74.
[10] Park JO, Lee SI, Song SY, et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria[J]. Jpn J Clin Oncol, 2003, 33(10): 533-537.
[11] 严广斌.NRS疼痛数字评价量表numerical rating scale[J/CD]. 中华关节外科杂志,2014,8(3): 410-410. YAN Guangbin. Numerical rating scale[J]. J Joint Surgery(Electronic Version), 2014, 8(3): 410-410.
[12] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources,methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): 359-386.
[13] Han DS, Suh YS, Kong SH, et al. Nomogmm predicting long-term survival after d2 gastrectomy for gastric cancer[J]. J Clin Oncol, 2012, 30(31): 3834-3840.
[14] Deng J, Liang H, Wang D, et al. Investigation of the recurrence patterns of gastric cancer following a curative resection[J]. Surg Today, 2011, 41(2): 210-215.
[15] Bang YJ, Kim YW, Yang HK, et al. CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy(CLASSIC): a phase 3 open-1abel, randomised controlled trial[J]. Lancet, 2012, 379(9813): 315-321.
[16] 吴晖,张信华,徐建波,等.进展期胃癌腹主动脉旁淋巴结转移的相关因素及其对预后的影响[J/CD].消化肿瘤杂志,2012,4(2):82-88. WU Hui, ZHANG Xinhua, XU Jianbo, et al. Influencing factors and prognostic impact of para-aortic lymph nodes metastasis in advancedgastric cancer[J/CD]. J Dig Oncol(Electronic Version), 2012, 4(2): 82-88.
[17] 张佳佳,梁振威,李颖,等.SiewertⅡ型和Ⅲ型局部晚期胃食管交界处腺癌根治术后淋巴结复发规律分析[J].中华放射肿瘤学杂志,2016,25(4): 356-361. ZHANG Jiajia, LIANG Zhenwei, LI Ying, et al. Pattern of nodal recurrence after curative resection in Siewert Ⅱ and Ⅲ locally advanced adenocarcinoma of gastroesophageal junction[J]. Chin J Radi Oncol, 2016, 25(4): 356-361.
[18] Deng J, Zhang R, Wu L, et al. Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer[J]. Ann Surg Oncol, 2015, 22(4): 1258-1266.
[19] Chen L, Wei S, Ye Z, et al. Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2017, 20(2): 218-223.
[20] Dai Y, Jiang J, Wang Y, et al. The correlation and clinical implication of VEGF-C expression in microvascular density andlymph node metastasis of gastric carcinoma[J]. Am J Transl Res, 2016, 8(12): 5741-5747.
[21] Yao L, Jiang Y, Jiang P, et al. CT-guided permanent ¹²⁵I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy[J]. Brachytherapy, 2015, 14(5): 662-669.
[22] Hori N, Kagawa S, Kikuchi S, et al. Multiple salvage radiotherapies for metachronous lymph node metastasis from gastric cancer contributed to long-term management of disease[J]. Gan To Kagaku Ryoho, 2017, 44(2): 165-167.
[23] 石亮荣,吴骏周,文杰,等.CT引导¹²⁵I粒子植入术治疗胃癌术后区域淋巴结转移[J].中华核医学与分子影像杂志,2013,33(4):243-248. SHI Liangrong, WU Junzhou, WEN Jie, et al. CT-guided ¹²⁵I seed implantation for Iocoregional lymph node metastases in pafients with recurrent gastric cancer[J]. Chinese Journal of Nuclear Medicine and Molecular Imaging, 2013, 33(4): 243-248.
[24] 王娟,孙美玲,张宏涛,等.外放疗后复发颈部淋巴结转移癌17例¹²⁵I粒子植入治疗的初步疗效[J].介入放射学杂志,2014,23(9): 784-787. WANG Juan, SUN Meiling, ZHANG Hongtao, et al. Radioactive ¹²⁵I seed implantation for the treatment of recurrent cervical lymphatic metastases after radiotherapy: preliminary results in 17 cases[J]. Journal of Interventional Radiology, 2014, 23(9): 784- 787.
[25] Wang Z, Lu J, Gong J, et al. CT-guided radioactive ¹²⁵I seed implantation therapy of symptomatic retroperitoneal lymph node metastases[J]. Cardiovasc Intervent Radiol, 2014, 37(1): 125-131.

相关文章 15

[1]	李星凯,刘战业,姜运峰,李军. 原发性中央型和周围型肺鳞癌临床病理学及预后差异[J]. 山东大学学报（医学版）, 2017, 55(9): 73-78.
[2]	赵文博,甄长青,袁代,单宁宁,王娜,封丽丽,李沛沛,丁梅,李英,张凌岩,王欣. 膦甲酸钠治疗血液病患者合并EB病毒感染的临床疗效[J]. 山东大学学报（医学版）, 2017, 55(9): 96-99.
[3]	聂思月,王震,孙靖宇,刘杰,李娟,魏小娟,路春晓,吕兴龑,王淑云,孙玉萍. ANGPTL5在人胃癌组织中的表达及临床意义[J]. 山东大学学报（医学版）, 2017, 55(8): 61-65.
[4]	颜进项,孟雷,董亚南,张爱军,岳洪胜,李波,钟良君,白爱国. 优化救治流程与Solitaire FR支架在治疗急性脑动脉闭塞中的应用[J]. 山东大学学报（医学版）, 2017, 55(7): 49-54.
[5]	林琦,张颖,戴建建,徐瑞彩,杨琦,耿宝成,韩明勇. CT引导放射性¹²⁵I粒子植入治疗23例浅表淋巴结转移瘤[J]. 山东大学学报（医学版）, 2017, 55(2): 38-44.
[6]	刘松涛,沈斌,林辉,李香伟,温昭科. 全胸腔镜下心脏不停跳与停跳二尖瓣置换术的对比[J]. 山东大学学报（医学版）, 2016, 54(8): 39-43.
[7]	王军锋,刘倩,孙小刚,李金良,徐加龙,吕其刚,马楠,王若义. 门静脉左支血管转流术治疗小儿门静脉海绵样变性的疗效评估[J]. 山东大学学报（医学版）, 2016, 54(7): 28-32.
[8]	徐闯,戚大春,李贤让,祖萌,李健,刘明廷. 初次髋关节置换术后引流与否的Meta分析[J]. 山东大学学报（医学版）, 2016, 54(6): 43-49.
[9]	张斌,张良文,迟令懿,王传伟,朱树干. 显微血管减压术治疗原发性三叉神经痛疗效的相关因素[J]. 山东大学学报（医学版）, 2016, 54(6): 69-72.
[10]	张明明,安永辉,韩彩莉,张瑛琪,马明,李娜,邹长鹏. CIK细胞联合光动力治疗中晚期食管癌的疗效观察[J]. 山东大学学报（医学版）, 2016, 54(1): 38-41.
[11]	丁娟, 郑桂喜, 杜鲁涛, 尹作花, 张建, 王传新. 外周血sHLA-G与PGR、GPR联合检测在胃癌诊断中的效能评估[J]. 山东大学学报（医学版）, 2015, 53(11): 59-63.
[12]	王玉琴, 哈秀英, 徐卫国. 三种抗精神分裂症药物的疗效和经济学评价[J]. 山东大学学报（医学版）, 2014, 52(Z2): 196-197.
[13]	闫文明, 王宏伟. 鼻咽癌同步放化疗的远期疗效分析[J]. 山东大学学报（医学版）, 2014, 52(S2): 91-91.
[14]	张诤, 申洪昌, 付国斌, 张建超, 王潍博. GRK6在胃癌中的表达及其预后价值[J]. 山东大学学报（医学版）, 2014, 52(7): 50-55.
[15]	连海峰, 李明, 刘成霞, 贾兴芳, 李丹. NRP2在胃癌中的表达及其临床意义[J]. 山东大学学报（医学版）, 2014, 52(7): 56-59.

多维度评价

Viewed

Full text

214

HTML			PDF

Just accepted	Online first	Issue	Just accepted	Online first	Issue
0	0	0	0	0	214

From	Others	local

Times	57	157
Rate	27%	73%

Abstract

2014

Just accepted	Online first	Issue

0	0	2014

	From	Others

	Times	2014
	Rate	100%

Cited

Web of Science	Crossref	ScienceDirect	Search for Citations in Google Scholar >>


This page requires you have already subscribed to WoS.

Shared

Discussed

CT引导下¹²⁵I粒子植入治疗晚期胃癌淋巴结转移

CT-guided ¹²⁵I seed implantation for lymph node metastases in patients with gastric cancer of later stage

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

多维度评价

本文评价

推荐阅读 0